Navigation Links
Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout
Date:5/17/2012

ISELIN, N.J., May 17, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout. This phase 2a trial was conducted at the Duke Clinical Research Unit of Duke University and the principal investigator was John Sundy, MD, PhD, an expert and key opinion leader in the treatment of gout. The trial was designed to assess the safety and efficacy of levotofisopam as a uric acid-lowering agent in patients with gout.

The trial enrolled 13 patients in an open label study with patients confined in the Duke facility.  The study enrolled patients with screening serum urate between 8 and 12 mg/dL. Subjects received a single dose of 50 mg on days 1 and 7 and 50 mg TID on days 2 through 6.  Levotofisopam was well tolerated. The mean reduction in serum urate was over 45%. All 13 patients were responders, and demonstrated a serum urate level of less than 6 mg/dL on day 7. Seven subjects achieved a serum urate level less than 4 mg/dL on day 7. Additionally there was an increase in the fractional excretion of urate, confirming the compound's mechanism of action as a uricosuric agent that enhances urate excretion by the kidneys. 

Commenting on the results of this Phase 2a trial, the principal investigator Dr. John Sundy said, "monotherapy with levotofisopam was well tolerated and induced clinically important reductions in serum urate levels in all patients studied. These results support further development of levotofisopam for treating hyperuricemia in patients with gout."

This trial follows two prior phase 1 clinical studies conducted by Vela Pharmaceuticals (merged with Pharmos in October 2006). In these studies, conducted in healthy volunteers in the United Kingdom and The Netherlands, levotofisopam treatment was generally well tolerated and was associated with
'/>"/>

SOURCE Pharmos Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmos Corporation Reports First Quarter 2012 Results
2. Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results
3. Pharmos Corporation Reports 2011 Second Quarter Results
4. Pharmos Corporation Reports 2010 Third Quarter Results
5. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
6. Pharmos Corporation Reports 2009 Third Quarter Results
7. Pharmos Issues Business Update on Dextofisopam Trial and Financing
8. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
9. Henry Schein Ranks #303 In 2012 FORTUNE 500® Ranking Of Americas Largest Corporations
10. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Colo. , May 24, 2013  Heska Corporation (NASDAQ: ... diagnostic and specialty products, announced today that Dr. ... officer, and Jason Napolitano , executive vice ... Annual Marcum MicroCap Conference, which is being held May 30, ... the Grand Hyatt Hotel. The Company,s presentation ...
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
(Date:5/23/2013)... , May 23, 2013 Neurocrine Biosciences, Inc. ... Kevin Gorman , President and Chief Executive Officer of ... th Annual dbAccess Health Care Conference in Boston.   ... 30 at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific ... on the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... (Nasdaq: IDIX ) announced today that Idenix management ... Small Cap Healthcare Conference on Tuesday, September 14, 2010 at ... City and at the Stifel Nicolaus Healthcare Conference on Thursday, ... Seasons Hotel, Boston. The live and archived ...
... YORK, Sept. 7 Reportlinker.com announces that a ... catalogue: Cell Therapy - Technologies, ... SummaryThis report describes ... have already started to play an important role ...
Cached Medicine Technology:Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 2Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 3Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 4Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 5Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 6Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 7Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 8Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 9Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 10Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 11Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 12Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 13Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 14Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 15Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 16Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 17Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 18Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 19Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 20
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
(Date:5/25/2013)... 25, 2013 According to a ... Market, 2013–2018", published by MarketsandMarkets is expected to ... of 5.54% which analyzes and studies the major ... Europe, Asia, and Rest of the World. , ... Tables , 87 Figures , ...
(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...
(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...
(Date:5/25/2013)... 25, 2013 Ayurveda is the ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... order to re-establish optimal health, one must discover where we ... style which brings us back into perfect harmony. , The ...
Breaking Medicine News(10 mins):Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2
... A new national plan of action provides a roadmap for ... and often unrecognized brain condition that affects approximately seven million ... to Bring an Ancient Disease into the 21st Century," written ... supplement to the Nov. 2011 issue of the Journal ...
... InDevR, a Boulder-based biotechnology company that develops ... of viruses and other microorganisms, announced today the ... a colorimetric detection system that incorporates core technology ... Office, will enhance laboratories around the world by ...
... News) -- One in 12 teens deliberately harm themselves, but ... young adults, a new study shows. Self-harm, which includes ... suicide and is especially common among females aged 15 to ... , where the finding appears Nov. 16 online. In ...
... Goodwin HealthDay Reporter , WEDNESDAY, Nov. 16 (HealthDay News) ... becoming obese adults at higher risk of type 2 diabetes, high ... But if they manage to get their weight under control ... of those health problems than people who were normal weight all ...
... (HealthDay News) -- A new study offers further evidence that ... research found that unsaturated fats from foods such as avocados, ... insulin. Reduced insulin action can lead to diabetes, which is ... three different types of balanced diets consumed by 164 people ...
... at the University of California, San Diego School of Medicine ... a specific sugar molecule with a pair of cell-killing drugs ... themselves, a process called apoptosis or programmed cell death. ... Research. "The goal of targeted therapy is to ...
Cached Medicine News:Health News:Protecting our brains: Tackling delirium 2Health News:Protecting our brains: Tackling delirium 3Health News:Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU 2Health News:One in 12 Teens Engages in Self-Harm: Report 2Health News:Outlook Good for Obese Kids Who Lose Weight 2Health News:Outlook Good for Obese Kids Who Lose Weight 3Health News:Even Without Weight Loss, Mediterranean Diet Helps Heart: Study 2Health News:New drug combo targets multiple cancers 2
... Professional Package is the best ... laboratory. The package includes the ... additional mounting blocks, v-block adapter, ... a sapphire blade for the ...
... Plus Sectioning System provides a versatile means ... plant tissues. The 3000 employs a ... freezing or embedding. The creation of ... of enzyme activities, and other deleterious effect ...
... The Vibratome 1500 Sectioning System provides a ... animal, or plant tissues. The 1500 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades....
Medicine Products: